future of protein production with plates with healthy food and protein

Verley names former Perfect Day executive COO and opens US branch

November 17, 2026

Verley has appointed former Perfect Day executive Shayri Roychoudhury as Chief Operating Officer and opened a US branch as the French precision fermentation company prepares to commercialize its FermWhey dairy protein ingredients.

• Shayri Roychoudhury joins Verley after seven years at Perfect Day.
• US branch supports the company’s first commercial market.
• Manufacturing expansion follows production at up to 50,000L scale.

Roychoudhury will lead Verley’s global operations organization and manufacturing network, with immediate responsibility for delivering its first commercial product, establishing cost-effective production partnerships and building repeatable industrial processes.

The appointment, announced on November 17, follows production at up to 50m³, equivalent to 50,000L, through manufacturing partnerships already in place. Verley is now working to expand capacity and strengthen the network needed to supply customers.

“What impressed me about Verley is not only the strength of its precision fermentation platform, but also its patented functionalization technologies, which bring an entirely new dimension to what dairy proteins can achieve in food applications,” Roychoudhury says.

“The team has already made remarkable progress across scientific development, commercial traction and industrial readiness, with a level of capital efficiency that stands out in the industry.”

Roychoudhury brings more than 18 years of experience across industrial biotechnology, fermentation scale-up and commercial manufacturing. Her background includes process and pilot-scale engineering, supply chain, quality, contract manufacturing and capital projects.

She spent seven years at Perfect Day, joining as employee number 29 and helping develop its manufacturing operations as the business moved from pre-commercial technology to industrial production of precision-fermented dairy proteins.

According to Verley, her responsibilities included building and leading manufacturing, contract manufacturing operations, supply chain, quality and capital projects. She also helped establish Perfect Day’s manufacturing partnership and joint venture in India, described in the announcement as having a roadmap toward approximately 3,500 metric tons of annual production by 2028.

At Verley, she has already begun building the operations team and developing a global contract manufacturing organization network, with partnerships across key manufacturing regions. Longer-term responsibilities include strategic arrangements intended to combine production scale with flexibility and capital efficiency.

“Having helped scale precision fermentation from early development to commercial manufacturing, I know how critical this next phase is,” Roychoudhury says. “My priority is to build the global Operations organization and manufacturing network that will enable Verley to deliver its first commercial products and establish a robust industrial platform for long-term growth.”

Roychoudhury is also Verley’s first US-based hire. She will help establish its operational presence in the country while coordinating international manufacturing activities.

The USA is the company’s first commercial market for FermWhey, following receipt of a US Food and Drug Administration “No Questions” letter. The November 17 announcement did not specify a commercial launch date.

“She has already helped establish the manufacturing operations, partnerships and supply chains required to bring precision-fermented proteins to industrial scale,” says Stéphane Mac Millan, Co-founder & CEO of Verley.

“Her appointment, together with the opening of our US branch, marks an important milestone in Verley’s development. We are strengthening our international presence and building the industrial capabilities needed to bring our technology to market.”

The expansion follows Verley’s US$38 million Series A announced in February. That financing was intended to support US market entry, customer scale-up, additional production capacity and continued ingredient development.

Verley produces beta-lactoglobulin, or BLG, a protein naturally found in whey, through precision fermentation. It then applies proprietary functionalization technologies to alter the protein’s behavior in food applications, including its stability, texture and gelling properties.

The company’s first US patent, announced in October, covers microparticulation of recombinant BLG. The technology allows Verley to tailor the protein’s physical properties for applications in which higher protein concentrations can create difficulties with viscosity, mouthfeel and processing stability.

Its FermWhey portfolio targets applications including high-protein beverages, active nutrition, healthy aging and specialized nutrition. The manufacturing work Roychoudhury will oversee is intended to provide the capacity and consistency required to supply those customers commercially.

“What particularly attracted me to Verley is the opportunity to turn a differentiated protein technology into products that food manufacturers can use at commercial scale,” she says.

‍If you liked this, check these out...

• Verley secures first US patent for dairy protein microparticulation technology‍
• Verley raises US$38 million Series A to take precision-fermented whey global as dairy strains under demand‍
• Ones to Watch: Whey ahead

Join Us At One Of Our Upcoming Events

If you have any questions or would like to get in touch with us, please email info@futureofproteinproduction.com

About the Speaker

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.